Gumintad, Joylyn G.
HRN: 22-80-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CEFUROXIME 1.5GM (VIAL)
03/20/2023
03/21/2023
IV
1.5 Gms
Q8hrs X 3 Doses
S/P Stat CS With IUD
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes